Diaceutics PLC (AIM:DXRX)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 202.75
-1.25 (-0.61%)
Nov 6, 2026, 4:10 PM GMT
Diaceutics Market Cap
Diaceutics has a market cap or net worth of 172.11 million as of November 6, 2026. It is the 19,537th most valuable company in the world and the 429th biggest in the United Kingdom. Its market cap has increased by 25.14% in one year.
Market Cap
172.11M
Enterprise Value
166.10M
Revenue
41.33M
Global Rank
Country Rank
#429 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since March 21, 2019, Diaceutics's market cap has increased from 66.45M to 172.11M, an increase of 159.00%. That is a compound annual growth rate of 13.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 170.20M | 56.59% |
| Dec 31, 2025 | 108.69M | 2.47% |
| Dec 31, 2024 | 106.07M | 44.67% |
| Dec 29, 2023 | 73.32M | 15.14% |
| Dec 30, 2022 | 63.68M | -25.74% |
| Dec 31, 2021 | 85.75M | -23.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 21, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 217.52B |
| GSK plc | 75.77B |
| Haleon | 29.74B |
| Smith & Nephew | 9.96B |
| Avacta Group | 279.90M |
| NIOX Group | 269.35M |
| Optima Health | 268.68M |
| Integrated Diagnostics Holdings | 199.27M |